Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-11-052179

Chief Financial Officer sold 12,500 shares at $0.22 ($2,688)

From the SEC's structured data for this filing

Trades in this filing

Lamadrid David · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2011-09-06 Sale : show line 1 in the form −12,500 $0.22 $2,688 7,837,500 D
Open-market sales · 12,500 sh · avg $0.22 · $2,688

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2011-09-06 Exercise or conversion : show line 2 in the form Stock Option −12,500 7,837,500 D
Loading xslF345X03/v234506_4.xml…